Skip to main content
. 2023 Jul 22;23:369. doi: 10.1186/s12872-023-03381-x

Table 2.

Cardiovascular disease outcomes of hypertension patients with different antihypertensive treatments

Antihypertensive treatment Hypertension (n) Cardiovascular disease (n) Percentage of cardiovascular disease outcomes (%) x2value P value
Regular 309 182 37.07 12.491  < 0.001
Irregular 49 62 55.86
Single-drug 97 75 43.60 9.170 0.010
Two-drug 150 63 29.58
Multi-drug 62 44 41.51
Single-drug 97 75 43.60 7.544 0.006
Two-drug 150 63 29.58
Two-drug 150 63 29.58 4.001 0.045
Multi-drug 62 44 41.51
Single-drug 97 75 43.60 0.048 0.827
Multi-drug 62 44 41.51
ACEis/ARBs + Beta-blockers 20 12 37.5 8.853 0.031
ACEis/ARBs + CCBs 73 18 19.8
ACEis/ARBs + Diuretics 24 8 25.0
Beta-blockers + CCBs 30 21 41.1

P values < 0.05 are written in italics

Values shown are n or (%). P values were calculated by chi-squared test, or Fisher’s exact test, as appropriate

Abbreviations: n Number, ACEi Angiotensin-converting enzyme inhibitor, ARB Angiotensin receptor antagonist, CCB Calcium channel receptor blocker